Recce Pharmaceuticals Ltd

ASX:RCE Stock Report

Market Cap: AU$109.0m

Recce Pharmaceuticals Management

Management criteria checks 2/4

Recce Pharmaceuticals' CEO is James Graham, appointed in Aug 2020, has a tenure of 4.25 years. total yearly compensation is A$834.51K, comprised of 62.8% salary and 37.2% bonuses, including company stock and options. directly owns 2.92% of the company’s shares, worth A$3.18M. The average tenure of the management team and the board of directors is 4.2 years and 6 years respectively.

Key information

James Graham

Chief executive officer

AU$834.5k

Total compensation

CEO salary percentage62.8%
CEO tenure4.3yrs
CEO ownership2.9%
Management average tenure4.2yrs
Board average tenure6yrs

Recent management updates

We Think Shareholders Are Less Likely To Approve A Pay Rise For Recce Pharmaceuticals Ltd's (ASX:RCE) CEO For Now

Nov 01
We Think Shareholders Are Less Likely To Approve A Pay Rise For Recce Pharmaceuticals Ltd's (ASX:RCE) CEO For Now

Recent updates

We Think Shareholders Are Less Likely To Approve A Pay Rise For Recce Pharmaceuticals Ltd's (ASX:RCE) CEO For Now

Nov 01
We Think Shareholders Are Less Likely To Approve A Pay Rise For Recce Pharmaceuticals Ltd's (ASX:RCE) CEO For Now

Here's Why We're Watching Recce Pharmaceuticals' (ASX:RCE) Cash Burn Situation

Feb 13
Here's Why We're Watching Recce Pharmaceuticals' (ASX:RCE) Cash Burn Situation

We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely

Jul 28
We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely

Recce Pharmaceuticals (ASX:RCE) Is In A Good Position To Deliver On Growth Plans

Dec 07
Recce Pharmaceuticals (ASX:RCE) Is In A Good Position To Deliver On Growth Plans

We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely

Aug 03
We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely

Recce Pharmaceuticals (ASX:RCE) Is In A Good Position To Deliver On Growth Plans

Mar 08
Recce Pharmaceuticals (ASX:RCE) Is In A Good Position To Deliver On Growth Plans

Need To Know: Recce Pharmaceuticals Ltd (ASX:RCE) Insiders Have Been Selling Shares

Feb 01
Need To Know: Recce Pharmaceuticals Ltd (ASX:RCE) Insiders Have Been Selling Shares

Could The Recce Pharmaceuticals Ltd (ASX:RCE) Ownership Structure Tell Us Something Useful?

Dec 09
Could The Recce Pharmaceuticals Ltd (ASX:RCE) Ownership Structure Tell Us Something Useful?

CEO Compensation Analysis

How has James Graham's remuneration changed compared to Recce Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$835kAU$524k

-AU$18m

Mar 31 2024n/an/a

-AU$14m

Dec 31 2023n/an/a

-AU$11m

Sep 30 2023n/an/a

-AU$12m

Jun 30 2023AU$775kAU$551k

-AU$13m

Mar 31 2023n/an/a

-AU$14m

Dec 31 2022n/an/a

-AU$15m

Sep 30 2022n/an/a

-AU$13m

Jun 30 2022AU$548kAU$328k

-AU$11m

Mar 31 2022n/an/a

-AU$10m

Dec 31 2021n/an/a

-AU$8m

Sep 30 2021n/an/a

-AU$11m

Jun 30 2021AU$2mAU$294k

-AU$14m

Mar 31 2021n/an/a

-AU$13m

Dec 31 2020n/an/a

-AU$13m

Sep 30 2020n/an/a

-AU$9m

Jun 30 2020AU$216kAU$187k

-AU$4m

Mar 31 2020n/an/a

-AU$4m

Dec 31 2019n/an/a

-AU$3m

Sep 30 2019n/an/a

-AU$3m

Jun 30 2019AU$177kAU$155k

-AU$3m

Mar 31 2019n/an/a

-AU$2m

Dec 31 2018n/an/a

-AU$2m

Sep 30 2018n/an/a

-AU$2m

Jun 30 2018AU$160kAU$142k

-AU$2m

Compensation vs Market: James's total compensation ($USD543.97K) is above average for companies of similar size in the Australian market ($USD298.50K).

Compensation vs Earnings: James's compensation has increased whilst the company is unprofitable.

CEO

James Graham

4.3yrs

Tenure

AU$834,509

Compensation

Mr. James Hamilton-Bray Graham, B.Com. (Entrepreneurship), GAICD, serves as Chief Executive Officer at Recce Pharmaceuticals Ltd since August 28, 2020 and also serves as Managing Director since 2020. He ha...

Leadership Team

NamePositionTenureCompensationOwnership
John K. Prendergast
Executive Chairman of the Board6.6yrsAU$380.55k0.13%
A$ 144.2k
James Graham
CEO, MD & Executive Director4.3yrsAU$834.51k2.92%
A$ 3.2m
Michele Dilizia
Chief Scientific Director & Executive Director4.2yrsAU$530.84k1.33%
A$ 1.4m
Justin Ward
Principal Quality Chemist & Executive Directorno dataAU$318.53k0.13%
A$ 141.7k
Arthur Kollaras
Principal Engineer & Head of Manufacturingno dataAU$564.01k0.040%
A$ 43.3k
Alan Dunton
Chief Medical Advisor & Independent Non Executive Directorno dataAU$75.00k0.055%
A$ 59.6k
Justin Reynolds
Chief Financial Officer7yrsno datano data
Daniel Astudillo
Head of Marketing4.8yrsno datano data
Maggie Niewidok
Company Secretary2.2yrsno datano data

4.2yrs

Average Tenure

Experienced Management: RCE's management team is considered experienced (4.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
John K. Prendergast
Executive Chairman of the Board6.6yrsAU$380.55k0.13%
A$ 144.2k
James Graham
CEO, MD & Executive Director9.4yrsAU$834.51k2.92%
A$ 3.2m
Michele Dilizia
Chief Scientific Director & Executive Director9.4yrsAU$530.84k1.33%
A$ 1.4m
Justin Ward
Principal Quality Chemist & Executive Director5.3yrsAU$318.53k0.13%
A$ 141.7k
Alan Dunton
Chief Medical Advisor & Independent Non Executive Director4.3yrsAU$75.00k0.055%
A$ 59.6k
Alistair McKeough
Non-Executive Director2.2yrsAU$81.25k0.011%
A$ 12.2k

6.0yrs

Average Tenure

Experienced Board: RCE's board of directors are considered experienced (6 years average tenure).